Coloplast has the best worldwide patient reputation among 28 leading medico companies. That is the conclusion from the independent, UK research organisation: PatientView, who has conducted a survey and asked 428 patient organisations in 54 countries.
Coloplast is the overall winner for the third year running and ranks number one in three out of six categories. Coloplast thus beats one of its closest competitors Convatec (second place) as well as St. Jude Medical (third) and Novo Nordisk (fourth).
“The best kind of recognition is that coming from the users, so we are extremely happy to see that our effort is noted. However, others are also doing well and are catching up with us,” says Senior Vice President of Global Marketing in Coloplast, Nicolas Nemery. Coloplast won in both 2012 and 2013 in all six categories in the PatientView survey.
“We want to create impactful improvements for people who use our products – and this survey indicates that this is appreciated,” says Nicolas Nemery.
“We’re pursuing a strategy that puts the user in the center. The majority of our users have had critical accidents or diseases, and we want to help them return to their normal lives. We can only do that by listening to their needs and incorporating them into everything we do.”
“We hope to remove some of the “patient stigma” that many live with – for instance by designing products that do not look like hospital equipment but instead look like products you would normally have in your handbag or in the bathroom.
Read more about the survey at PatientView’s website.
Read more about Coloplast at www.coloplast.com.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Our business includes ostomy care, urology and continence care and wound and skin care.
The survey examined the reputation of the medico industry as a whole, and the asked patient groups rated the individual reputation of the companies in six different areas:
• Whether the company has an effective patient-centered strategy (1st )
• The quality of the information that the company provides to patients (1st )
• The company’s record on patient safety (1st )
• The usefulness of the company’s products to patients (2nd )
• Record of transparency with external healthcare stakeholders (2nd )
• Whether the company acts with integrity (3rd)
Top medical device performance – overall rankings 2013-2014
Coloplast A/S – 1st
Convatec – 2nd
St Jude Medical – 3rd
Novo Nordisk A/S – 4th
Roche Diagnostics – 5th
Sanofi – 6th
28 companies were included in the survey
Coloplast A/S, ConvaTec, St Jude Medical, Smith & Nephew, Novo Nordisk A/S, Roche Diagnostics, Sanofi, Fresenius Medical Care, Abbott Laboratories, Medtronic, Inc, Johnson & Johnson, Ortho Clinical Diagnostics, Inc, Philips Healthcare, Baxter International, Kimberly-Clark, GE Healthcare, B. Braun Melsungen AG, 3M Healthcare, Becton Dickinson, Olympus Medical Business, Mölnlycke Health Care, Toshiba Medical Systems Corporation, Alcon, Boston Scientific, Bausch + Lomb, Hartmann Group, Biotronik International, Siemens Healthcare
The asked patient groups represent at least 1.5 million patients and cover a broad range of care areas, including neurology, cancer, diabetes and mental health. The majority (16 percent) is from Great Britain, 10 percent from Germany, 9 percent from the US. The rest is scattered from countries around the world. The survey was conducted from mid-February to end March 2014.